Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.12 is in line with its 5-year average of 1.23, near the low end of its 5-year range (0.92–1.64).
As of the fiscal period ended Tuesday, June 30, 2026. 7.89% above its 12-month average of 1.04.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.12.
CURRENT RATIO
1.12
CURRENT RATIO AVG TTM
1.04
CURRENT RATIO AVG 3Y
1.18
CURRENT RATIO AVG 5Y
1.23
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.89%
CURRENT VS 3Y AVG
-4.52%
CURRENT VS 5Y AVG
-8.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 746 covered companies
CURRENT VS SECTOR MEDIAN
-68.59%
vs the sector median at left
Market Cap
$783.39M
Current Ratio
1.38
TTM Avg
2.71
3Y Avg
3.18
5Y Avg
5.09
Market Cap
$797.70M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$777.34M
Current Ratio
13.37
TTM Avg
5.16
3Y Avg
5.50
5Y Avg
4.90
Market Cap
$774.54M
Current Ratio
9.39
TTM Avg
11.79
3Y Avg
11.79
5Y Avg
11.79
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $797.26M | 1.12 | 1.04 | 1.18 | 1.23 |
| Apnimed, Inc. (APMD)vs › | $790.49M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $789.07M | 6.92 | 5.11 | 3.93 | 4.38 |
| Sana Biotechnology, Inc. (SANA)vs › | $783.39M | 1.38 | 2.71 | 3.18 | 5.09 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.70M | 4.26 | 4.46 | 3.96 | 4.08 |
| InMode Ltd. (INMD)vs › | $805.59M | 8.18 | 10.05 | 10.24 | 9.72 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | 13.37 | 5.16 | 5.50 | 4.90 |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | 3.34 | 4.45 | 4.03 | 4.25 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.54M | 9.39 | 11.79 | 11.79 | 11.79 |
| Mesa Laboratories, Inc. (MLAB)vs › | $773.13M | 2.07 | 1.18 | 1.89 | 3.24 |
Current Ratio
1.12
Quick Ratio
0.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.12 |
| 2026-04-10 | 0.92 |
| 2025-12-31 | 1.02 |
| 2025-09-30 | 1.08 |
| 2025-06-30 | 1.06 |
| 2025-03-31 | 1.29 |
| 2024-12-31 | 1.33 |
| 2024-09-30 | 1.24 |
| 2024-06-30 | 1.15 |
| 2024-03-31 | 1.33 |
| 2023-12-31 | 1.21 |
| 2023-09-30 | 1.31 |
| 2023-06-30 | 1.24 |
| 2023-03-31 | 1.23 |
| 2022-12-31 | 1.28 |
| 2022-09-30 | 1.35 |
| 2022-06-30 | 1.39 |
| 2022-03-31 | 1.39 |
| 2021-12-31 | 1.34 |
| 2021-09-30 | 1.64 |
| 2021-06-30 | 0.98 |
| 2021-03-31 | 0.98 |
| 2020-12-31 | 0.86 |
| 2020-09-30 | 1.54 |
| 2020-06-30 | 1.03 |
| 2020-03-31 | 1.02 |
| 2019-12-31 | 1.18 |
| 2019-09-30 | 0.23 |
| 2019-06-30 | 0.44 |
| 2019-03-31 | 0.93 |
| 2018-12-31 | 1.58 |
| 2018-09-30 | 2.86 |
| 2018-06-30 | 13.06 |
| 2018-03-31 | 16.75 |
